SLC25A22 and gallbladder carcinoma: Moreover, Du et al. demonstrated that inhibition of SLC25A22 by the MAPK/ERK pathway could promote mitochondrial apoptosis, thus inhibiting the growth and proliferation gallbladder carcinoma cells [36]. Therefore, we examined the effects of AC010883.5 knockdown on the ERK/MAPK pathway.